|
|
||||||||
Research Paper |
Institut de Pharmacologie et de Biologie Structurale, Centre National de la Recherche Scientifique, Université Paul Sabatier (UMR5089), 205 route de Narbonne, 31077 Toulouse cedex, France1
Centre de Biochimie Structurale (INSERM U554 CNRS UMR5048 UM1), 29 rue de Navacelles, 34090 Montpellier cedex, France2
Author for correspondence: A. Quémard. Tel: +33 5 61 17 55 76. Fax: +33 5 61 17 59 94. e-mail: annaik{at}ipbs.fr
The fatty acid elongation system FAS-II is involved in the biosynthesis of mycolic acids, which are very long-chain fatty acids of the cell envelope specific to Mycobacterium tuberculosis and other mycobacteria. A potential component of FAS-II, the protein MabA (FabG1), was overexpressed and purified. Sedimentation equilibrium analyses revealed that MabA undergoes a dimer to tetramer self-association with a dissociation constant of 22 µM. The protein was detected by Western blotting in a mycobacterial cell-wall extract that produces mycolic acids and in the FPLC FAS-II fraction. MabA was shown to catalyse the NADPH-specific reduction of ß-ketoacyl derivatives, equivalent to the second step of a FAS-II elongation round. Unlike the known homologous proteins, MabA preferentially metabolizes long-chain substrates (C8C20) and has a poor affinity for the C4 substrate, in agreement with FAS-II specificities. Molecular modelling of MabA structure suggested the presence of an unusually hydrophobic substrate-binding pocket holding a unique Trp residue, suitable for fluorescence spectroscopic analyses. In agreement with the enzyme kinetic data, the spectral properties of MabA were different in the presence of the C8C16 ligands as compared to the C4 ligand. Altogether, these data bring out distinctive enzymic and structural properties of MabA, which correlate with its predilection for long-chain substrates, in contrast to most of the other known ketoacyl reductases.
Keywords: ß-ketoacyl reductase, quaternary structure, enzymic activity, structural model, fluorescence spectroscopy
Abbreviations: ACP, acyl carrier protein; ESI, electrospray ionization; FAS, fatty acid synthetase; H-MabA, His-tagged MabA; INH, isoniazid; MALDI-TOF, matrix-associated laser desorption ionization-time of flight; KAR, ß-ketoacyl-ACP reductase; PDB, Protein Data Bank; SDR, short-chain dehydrogenases/reductases
a Present address: St Jude Childrens Research Hospital, Dept of Biochemistry, 322 N Lauderdale, Memphis, TN 38105, USA.
b Hedia Marrakchi and Stéphanie Ducasse contributed equally to this work.
This article has been cited by other articles:
![]() |
K. Holsch, J. Havel, M. Haslbeck, and D. Weuster-Botz Identification, Cloning, and Characterization of a Novel Ketoreductase from the Cyanobacterium Synechococcus sp. Strain PCC 7942 Appl. Envir. Microbiol., November 1, 2008; 74(21): 6697 - 6702. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Sacco, A. S. Covarrubias, H. M. O'Hare, P. Carroll, N. Eynard, T. A. Jones, T. Parish, M. Daffe, K. Backbro, and A. Quemard The missing piece of the type II fatty acid synthase system from Mycobacterium tuberculosis PNAS, September 11, 2007; 104(37): 14628 - 14633. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. A. Kruh, R. Rawat, B. P. Ruzsicska, and P. J. Tonge Probing mechanisms of resistance to the tuberculosis drug isoniazid: Conformational changes caused by inhibition of InhA, the enoyl reductase from Mycobacterium tuberculosis Protein Sci., August 1, 2007; 16(8): 1617 - 1627. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Parish, G. Roberts, F. Laval, M. Schaeffer, M. Daffe, and K. Duncan Functional Complementation of the Essential Gene fabG1 of Mycobacterium tuberculosis by Mycobacterium smegmatis fabG but Not Escherichia coli fabG J. Bacteriol., May 15, 2007; 189(10): 3721 - 3728. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. T. Nomura, K. Taguchi, Z. Gan, K. Kuwabara, T. Tanaka, K. Takase, and Y. Doi Expression of 3-Ketoacyl-Acyl Carrier Protein Reductase (fabG) Genes Enhances Production of Polyhydroxyalkanoate Copolymer from Glucose in Recombinant Escherichia coli JM109 Appl. Envir. Microbiol., August 1, 2005; 71(8): 4297 - 4306. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Takayama, C. Wang, and G. S. Besra Pathway to Synthesis and Processing of Mycolic Acids in Mycobacterium tuberculosis Clin. Microbiol. Rev., January 1, 2005; 18(1): 81 - 101. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Schweizer and J. Hofmann Microbial Type I Fatty Acid Synthases (FAS): Major Players in a Network of Cellular FAS Systems Microbiol. Mol. Biol. Rev., September 1, 2004; 68(3): 501 - 517. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ducasse-Cabanot, M. Cohen-Gonsaud, H. Marrakchi, M. Nguyen, D. Zerbib, J. Bernadou, M. Daffe, G. Labesse, and A. Quemard In Vitro Inhibition of the Mycobacterium tuberculosis {beta}-Ketoacyl-Acyl Carrier Protein Reductase MabA by Isoniazid Antimicrob. Agents Chemother., January 1, 2004; 48(1): 242 - 249. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Rawat, A. Whitty, and P. J. Tonge The isoniazid-NAD adduct is a slow, tight-binding inhibitor of InhA, the Mycobacterium tuberculosis enoyl reductase: Adduct affinity and drug resistance PNAS, November 25, 2003; 100(24): 13881 - 13886. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |